Ally Bridge Group
Latest statistics and disclosures from Ally Bridge Group's latest quarterly 13F-HR filing:
- Top 5 stock holdings are ITCI, TARS, INSM, AXSM, XENE, and represent 34.75% of Ally Bridge Group's stock portfolio.
- Added to shares of these 10 stocks: ITCI (+$12M), AXSM (+$5.6M), SLNO, KRRO, EYPT, Aadi Bioscience, ATYR, ETNB, DNTH, ALMS.
- Started 9 new stock positions in DNTH, AXSM, ITCI, EYPT, ATYR, ETNB, SLNO, KRRO, Aadi Bioscience.
- Reduced shares in these 10 stocks: SRPT (-$9.0M), TARS (-$8.2M), Longboard Pharmaceuticals In (-$8.0M), RVMD (-$7.4M), SWTX (-$6.3M), JSPR (-$5.9M), KURA (-$5.7M), APLT (-$5.3M), IRON, CATX.
- Sold out of its positions in APLT, IRON, CATX, KURA, Longboard Pharmaceuticals In, RLAY, RVMD, SRPT.
- Ally Bridge Group was a net seller of stock by $-67M.
- Ally Bridge Group has $117M in assets under management (AUM), dropping by -37.57%.
- Central Index Key (CIK): 0001822947
Tip: Access up to 7 years of quarterly data
Positions held by Ally Bridge Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Ally Bridge Group
Ally Bridge Group holds 30 positions in its portfolio as reported in the December 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Intra Cellular Therapies (ITCI) | 10.6 | $12M | NEW | 148k | 83.52 |
|
| Tarsus Pharmaceuticals (TARS) | 8.2 | $9.6M | -46% | 173k | 55.37 |
|
| Insmed Com Par $.01 (INSM) | 6.8 | $7.9M | -24% | 114k | 69.04 |
|
| Axsome Therapeutics (AXSM) | 4.8 | $5.6M | NEW | 67k | 84.61 |
|
| Xenon Pharmaceuticals (XENE) | 4.3 | $5.1M | -38% | 129k | 39.20 |
|
| Cg Oncology (CGON) | 4.3 | $5.0M | -33% | 174k | 28.68 |
|
| Merus N V (MRUS) | 4.2 | $4.9M | -43% | 117k | 42.05 |
|
| Blueprint Medicines (BPMC) | 4.2 | $4.9M | -47% | 56k | 87.22 |
|
| Janux Therapeutics (JANX) | 4.1 | $4.8M | -17% | 90k | 53.54 |
|
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 3.5 | $4.1M | -21% | 245k | 16.75 |
|
| Soleno Therapeutics (SLNO) | 3.4 | $3.9M | NEW | 88k | 44.95 |
|
| Geron Corporation (GERN) | 3.3 | $3.8M | -19% | 1.1M | 3.54 |
|
| Alumis (ALMS) | 3.0 | $3.5M | +6% | 445k | 7.86 |
|
| Praxis Precision Medicines I Com New (PRAX) | 3.0 | $3.5M | -38% | 45k | 76.96 |
|
| Trevi Therapeutics (TRVI) | 2.8 | $3.2M | -40% | 782k | 4.12 |
|
| Enliven Therapeutics (ELVN) | 2.7 | $3.2M | -39% | 142k | 22.50 |
|
| Korro Bio (KRRO) | 2.3 | $2.7M | NEW | 71k | 38.07 |
|
| Jasper Therapeutics Com New (JSPR) | 2.2 | $2.6M | -69% | 122k | 21.38 |
|
| Eyepoint Pharmaceuticals Com New (EYPT) | 2.2 | $2.6M | NEW | 348k | 7.45 |
|
| Aadi Bioscience | 2.2 | $2.6M | NEW | 818k | 3.15 |
|
| Atyr Pharma Com New (ATYR) | 2.2 | $2.5M | NEW | 700k | 3.62 |
|
| 89bio (ETNB) | 2.1 | $2.5M | NEW | 318k | 7.82 |
|
| Tyra Biosciences (TYRA) | 2.1 | $2.4M | -35% | 175k | 13.90 |
|
| Dianthus Therapeutics (DNTH) | 2.0 | $2.3M | NEW | 106k | 21.80 |
|
| Mind Medicine Mindmed Com New (MNMD) | 2.0 | $2.3M | -58% | 330k | 6.96 |
|
| Edgewise Therapeutics (EWTX) | 1.9 | $2.2M | -55% | 83k | 26.70 |
|
| Springworks Therapeutics (SWTX) | 1.7 | $2.0M | -75% | 55k | 36.13 |
|
| Context Therapeutics (CNTX) | 1.4 | $1.7M | -10% | 1.6M | 1.05 |
|
| Promis Neurosciences Com New (PMN) | 1.3 | $1.5M | 1.6M | 0.95 |
|
|
| Eliem Therapeutics (CLYM) | 1.2 | $1.4M | -38% | 760k | 1.80 |
|
Past Filings by Ally Bridge Group
SEC 13F filings are viewable for Ally Bridge Group going back to 2020
- Ally Bridge Group 2024 Q4 filed Feb. 14, 2025
- Ally Bridge Group 2024 Q3 filed Nov. 14, 2024
- Ally Bridge Group 2024 Q2 filed Aug. 14, 2024
- Ally Bridge Group 2024 Q1 filed May 15, 2024
- Ally Bridge Group 2023 Q4 filed Feb. 14, 2024
- Ally Bridge Group 2023 Q3 filed Nov. 14, 2023
- Ally Bridge Group 2023 Q2 filed Aug. 14, 2023
- Ally Bridge Group 2023 Q1 filed May 15, 2023
- Ally Bridge Group 2022 Q4 filed Feb. 14, 2023
- Ally Bridge Group 2022 Q3 filed Nov. 14, 2022
- Ally Bridge Group 2022 Q2 filed Aug. 15, 2022
- Ally Bridge Group 2022 Q1 filed May 16, 2022
- Ally Bridge Group 2021 Q4 filed Feb. 14, 2022
- Ally Bridge Group 2021 Q3 filed Nov. 15, 2021
- Ally Bridge Group 2021 Q2 filed Aug. 16, 2021
- Ally Bridge Group 2021 Q1 filed May 17, 2021